Skip to main content
. 2022 Aug 10;13:922264. doi: 10.3389/fendo.2022.922264

Table 1.

Baseline characteristics.

Normal weight (n = 113) Overweight (n = 169) P-value
Demographics
 Age (years) 66.42 ± 9.22 63.97 ± 9.51 0.033
 Male, n (%) 66 (58.41) 129 (76.33) 0.002
Cardiovascular risk factors
 Diabetes history 29 (25.66) 67 (39.64) 0.015
 BMI 22.49 (21.33-23.28) 26.45 (25.08-27.98) <0.01
 Hypertension history 74 (65.49) 125 (73.96) 0.126
 Hyperlipidemia history 19 (16.81) 40 (23.67) 0.166
 Atrial fibrillation history 5 (4.42) 9 (5.33) 0.787
 Post-PCI 90 (79.65) 131 (77.51) 0.670
 Smoking history 23 (20.35) 45 (26.63) 0.228
 Family history of CAD 4 (3.54) 8 (4.73) 0.768
 LVEF 63.00 (60.00-65.00) 63.00 (60.00-65.00) 0.899
Vital signs
 Systolic blood pressure (mmHg) 130.11 ± 21.80 136.71 ± 20.30 0.010
 Diastolic blood pressure (mmHg) 73.31 ± 11.75 78.09 ± 11.63 0.001
 Heart rate 73.00 (68.00-80.00) 76.00 (68.50-82.00) 0.144
Biochemical parameters
 TG (mmol/L) 1.19 (0.95-1.69) 1.46 (1.15-2.31) <0.01
 TC (mmol/L) 3.47 (2.98-4.14) 3.56 (2.93-4.28) 0.759
 LDL-C (mmol/L) 1.71 (1.40-2.28) 1.79 (1.34-2.41) 0.746
 HbA1c (g/L) 6.00 (5.65-6.75) 6.30 (5.80-7.10) 0.002

Values are shown as n (%), mean ± SD, or medians (interquartile ranges). BMI: body mass index. PCI: percutaneous coronary intervention; LVEF: left ventricular ejection fraction; TG: triglycerides. TC: total cholesterol; LDL-C: high-density lipoprotein; HbA1c: glycated hemoglobin.